310: Ignite Session 4A

Presentations:

• 10:00 AM – 10:05 AM Eastern Time

  Clinical Characteristics of Patients with ANCA-Associated Vasculitis with and Without Alpha-1 Antitrypsin Deficiency Alleles
  

  Ignite Speaker: Lynn Fussner, MD – The Ohio State University
• 10:05 AM – 10:10 AM Eastern Time

  WITHDRAWN
• 10:10 AM – 10:15 AM Eastern Time

  ANCA-Associated Vasculitis Treated with Avacopan versus a Standard Prednisone Taper: Glucocorticoid Toxicity Index Scores by Domain
  

  Ignite Speaker: John H. Stone, MD, MPH – Massachusetts General Hospital Rheumatology Unit, Harvard Medical School
• 10:15 AM – 10:20 AM Eastern Time

  Safety of Avacopan in ANCA-Associated Vasculitis: Combined Data from Three Clinical Trials
  

  Ignite Speaker: Peter Merkel, MD, MPH – University of Pennsylvania
• 10:20 AM – 10:25 AM Eastern Time

  Identification of Novel Proteomic Biomarkers of Disease Activity in ANCA-Associated Vasculitis Using a High Throughput Approach
  

  Ignite Speaker: Zachary Wallace, MD, MSc – Massachusetts General Hospital